Literature DB >> 8114302

[Association of autoimmune disease in primary biliary cirrhosis].

T Takagi1, R Kasukawa.   

Abstract

Association of autoimmune disease in patients with primary biliary cirrhosis (PBC) was described. Forty-one patients with asymptomatic PBC (a-PBC) and 13 patients with symptomatic PBC (s-PBC) were examined. The overall prevalence of autoimmune disease in association with PBC was 63%. There was no significant difference in the frequency of autoimmune disease association between a-PBC (63.4%) and s-PBC (61.5%). The most frequent complication was Sjögren's syndrome (31.7% in a-PBC and 38.5% in s-PBC). Raynaud's phenomenon was seen in 7 patients (12.2% in a-PBC and 15.4% in s-PBC). Five of these 7 patients showed the CREST syndrome having the anti-centromere antibody. Association of 3 polyarthritis, 2 autoimmune hepatitis, 2 Hashimoto's disease, 1 systemic lupus erythematosus, 1 polymyositis and 1 temporal arteritis was seen in a-PBC patients.

Entities:  

Mesh:

Year:  1994        PMID: 8114302

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

Review 1.  Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review.

Authors:  Joaquim Polido-Pereira; Ana Maria Rodrigues; Helena Canhão; Fernando Saraiva; José Alberto Pereira da Silva; João Eurico Fonseca
Journal:  Clin Rheumatol       Date:  2011-10-26       Impact factor: 2.980

2.  A study of the effects of saliva stimulation by nizatidine on dry mouth symptoms of primary biliary cirrhosis.

Authors:  Tetsu Kikuchi; Katsuharu Hirano; Takuya Genda; Hironori Tsuzura; Shunsuke Sato; Yoshio Kanemitsu; Yutaka Narita; Katsuyori Iijima; Takafumi Ichida
Journal:  World J Hepatol       Date:  2013-03-27

3.  A rare association of rheumatoid arthritis and primary biliary cirrhosis treated with rituximab: a case report.

Authors:  Faiza Lazrak; Fatima Ezzahra Abourazzak; Khadija Berrada; Nadira Kadi; Samia Manssouri; Taoufik Harzy
Journal:  J Med Case Rep       Date:  2013-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.